Evgen Pharma Plc

Evgen Pharma is an AIM listed clinical stage drug development company developing medicines for the treatment of multiple diseases focusing on Oncology.
Our lead programme has completed a study in patients with oestrogen-positive (ER+) metastatic breast cancer and will be entering a Ph2 study in Glioma patients (Glioblastoma multiforme) in H2 2022.
We are open to partnering discussions as well as in-licensing/acquisition opportunities in cancer therapeutics and supportive care.

Company type
Dr Helen Kuhlman
LinkedIn logo Chief Business Officer 
Dr Huw Jones
LinkedIn logo Chief Executive Officer 

Karma Oncology

Karma Oncology is a specialised oncology clinical development company headquartered in Scotland with offices in Netherlands and USA.  We offer a complete range of development services from clinical development planning, protocol design and authoring, strategic country/site selection, regulatory submissions, through to clinical trial execution and reporting. 

Adaptable - We can provide selected individual services, and extend to full-service global CRO capabilities clients require.  Our size allows us to be flexible, innovative and responsive to individual sponsor requirements and to adhere strictly to sponsor specified development timelines.

Reliable - Our Project Managers have extensive oncology experience, our monitors are professional, mature 'career' CRAs - not trainees - and we have the lowest staff turnover in the industry (<5%).  Many of our staff come from a nursing or medical background, and for international studies we use CRAs native to their country.

Motivated - Our team has successfully completed programs in a broad range of solid tumour and hematologic indications utilising an array of different therapeutic approaches including immunotherapy and cell therapies (autologous, CAR-T and CAR-NK).

Accountable – The Karma team focus on delivering quality while respecting sponsor timelines (not internal timelines) and will do what it takes to do so.

Twitter Account @KarmaOncology
Dr Karen J. Williams
LinkedIn logo CEO